{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:18:42Z","timestamp":1792459122227,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T00:00:00Z","timestamp":1730592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T00:00:00Z","timestamp":1730592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s10157-024-02573-9","type":"journal-article","created":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T04:22:38Z","timestamp":1730607758000},"page":"21-28","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Renal involvement in TAFRO syndrome: a review"],"prefix":"10.1007","volume":"29","author":[{"given":"Yoshifumi","family":"Ubara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,3]]},"reference":[{"key":"2573_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3960\/jslrt.53.63","volume":"53","author":"K Takai","year":"2013","unstructured":"Takai K, Nikkuni K, Momoi A, Nagai K, Igarashi N, Saeki T. Thrombocytopenia with reticulin fibrosis accompanied by fever, anasarca and hepatosplenomegaly: a clinical report of five cases. J Clin Exp Hematop. 2013;53:63\u20138.","journal-title":"J Clin Exp Hematop"},{"key":"2573_CR2","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/ajh.24242","volume":"91","author":"N Iwaki","year":"2016","unstructured":"Iwaki N, Fajgenbaum DC, Nabel CS, Gion Y, Kondo E, Kawano M, Masunari T, Yoshida I, Moro H, Nikkuni K, Takai K, Matsue K, Kurosawa M, Hagihara M, Saito A, Okamoto M, Yokota K, Hiraiwa S, Nakamura N, Nakao S, Yoshino T, Sato Y. Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicenteric Castleman disease. Am J Hematol. 2016;91:220\u20136.","journal-title":"Am J Hematol"},{"key":"2573_CR3","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s12185-016-1979-1","volume":"103","author":"Y Masaki","year":"2016","unstructured":"Masaki Y, Kawabata H, Takai K, Kojima M, Tsukamoto N, Ishigaki Y, Kurose N, Ide M, Murakami J, Nara K, Yamamoto H, Ozawa Y, Takahashi H, Miura K, Miyauchi T, Yoshida S, Momoi A, Awano N, Ikushima S, Ohta Y, Furuta N, Fujimoto S, Kawanami H, Sakai T, Kawanami T, Fujita Y, Fukushima T, Nakamura S, Kinoshita T, Aoki S. Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version. Int J Hematol. 2016;103:686\u201392.","journal-title":"Int J Hematol"},{"issue":"1","key":"2573_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s13730-018-0319-0","volume":"7","author":"S Noda-Narita","year":"2018","unstructured":"Noda-Narita S, Sumida K, Sekine A, Hoshino J, Mise K, Suwabe T, Hayami N, Yamanouchi M, Ueno T, Mizuno H, Kawada M, Hiramatsu R, Hasegawa E, Sawa N, Takaichi K, Ohashi K, Fujii T, Ubara Y. TAFRO syndrome with refractory thrombocytopenia responding to tocilizumab and romiplostim: a case report. CEN Case Rep. 2018;7(1):162\u20138.","journal-title":"CEN Case Rep"},{"key":"2573_CR5","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.humpath.2018.03.021","volume":"82","author":"H Mizuno","year":"2018","unstructured":"Mizuno H, Sekine A, Oguro M, Oshima Y, Kawada M, Sumida K, Yamanouchi M, Hayami N, Suwabe T, Hiramatsu R, Hasegawa E, Hoshino J, Sawa N, Fujii T, Takaichi K, Ohashi K, Ubara Y. Renal histology in a patient with TAFRO syndrome: a case report. Hum Pathol. 2018;82:258\u201363.","journal-title":"Hum Pathol"},{"issue":"15","key":"2573_CR6","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.2169\/internalmedicine.0529-22","volume":"62","author":"Y Nakayama","year":"2023","unstructured":"Nakayama Y, Mizuno H, Sawa N, Suwabe T, Yamanouchi M, Ikuma D, Hasegawa E, Hoshino J, Sekine A, Oba Y, Kono K, Kinowaki K, Ohashi K, Suzuki K, Sato Y, Shimizu A, Yamaguchi Y, Ubara Y. Adolescent-onset TAFRO syndrome with malignant nephrosclerosis-like lesions. Intern Med. 2023;62(15):2223\u20139.","journal-title":"Intern Med"},{"issue":"8","key":"2573_CR7","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.ekir.2020.05.004","volume":"5","author":"H Mizuno","year":"2020","unstructured":"Mizuno H, Sawa N, Watanabe S, Ikuma D, Sekine A, Kawada M, Yamanouchi M, Hasegawa E, Suwabe T, Hoshino J, Takaichi K, Kinowaki K, Fujii T, Ohashi K, Nagata M, Yamaguchi Y, Ubara Y. The clinical and histopathological feature of renal manifestation of TAFRO syndrome. Kidney Int Rep. 2020;5(8):1172\u20139.","journal-title":"Kidney Int Rep"},{"issue":"11","key":"2573_CR8","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","volume":"358","author":"V Eremina","year":"2008","unstructured":"Eremina V, Jefferson JA, Kowalewska J, Hochster H, Haas M, Weisstuch J, Richardson C, Kopp JB, Kabir MG, Backx PH, Gerber HP, Ferrara N, Barisoni L, Alpers CE, Quaggin SE. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med. 2008;358(11):1129\u201336.","journal-title":"N Engl J Med"},{"issue":"4","key":"2573_CR9","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10157-020-01986-6","volume":"25","author":"Y Ubara","year":"2021","unstructured":"Ubara Y, Kawaguchi T, Nagasawa T, Miura K, Katsuno T, Morikawa T, Ishikawa E, Ogura M, Matsumura H, Kurayama R, Matsumoto S, Marui Y, Hara S, Maruyama S, Narita I, Okada H, Tsuruya K, Committee of Practical Guide for Kidney Biopsy 2020. Kidney biopsy guidebook 2020 in Japan. Clin Exp Nephrol. 2021;25(4):325\u201364.","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"2573_CR10","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/ki.1992.76","volume":"41","author":"T Sakai","year":"1992","unstructured":"Sakai T, Lemley KV, Hackenthal E, Nagata M, Nobiling R, Kriz W. Changes in glomerular structure following acute mesangial failure in the isolated perfused kidney. Kidney Int. 1992;41(3):533\u201341.","journal-title":"Kidney Int"},{"issue":"20","key":"2573_CR11","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1182\/blood-2018-07-862334","volume":"132","author":"F van Rhee","year":"2018","unstructured":"van Rhee F, Voorhees P, Dispenzieri A, Foss\u00e5 A, Srkalovic G, Ide M, Munshi N, Schey S, Streetly M, Pierson SK, Partridge HL, Mukherjee S, Shilling D, Stone K, Greenway A, Ruth J, Lechowicz MJ, Chandrakasan S, Jayanthan R, Jaffe ES, Leitch H, Pemmaraju N, Chadburn A, Lim MS, Elenitoba-Johnson KS, Krymskaya V, Goodman A, Hoffmann C, Zinzani PL, Ferrero S, Terriou L, Sato Y, Simpson D, Wong R, Rossi JF, Nasta S, Yoshizaki K, Kurzrock R, Uldrick TS, Casper C, Oksenhendler E, Fajgenbaum DC. International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood. 2018;132(20):2115\u201324.","journal-title":"Blood"},{"issue":"14","key":"2573_CR12","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.2169\/internalmedicine.52.0271","volume":"52","author":"A Imafuku","year":"2013","unstructured":"Imafuku A, Suwabe T, Hasegawa E, Mise K, Sumida K, Hiramatsu R, Yamanouchi M, Hayami N, Hoshino J, Sawa N, Oohashi K, Fujii T, Okubo M, Takaichi K, Oga T, Ubara Y. Castleman\u2019s disease accompanied by hypolipidemic cerebral hemorrhage and nephrosclerosis. Intern Med. 2013;52(14):1611\u20136.","journal-title":"Intern Med"},{"issue":"3","key":"2573_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.5414\/CNP68171","volume":"68","author":"M Ogita","year":"2007","unstructured":"Ogita M, Hoshino J, Sogawa Y, Sawa N, Katori H, Takemoto F, Ubara Y, Hara S, Miyakoshi S, Takaichi K. Multicentric Castleman disease with secondary AA renal amyloidosis, nephrotic syndrome and chronic renal failure, remission after high-dose melphalan and autologous stem cell transplantation. Clin Nephrol. 2007;68(3):171\u20136.","journal-title":"Clin Nephrol"},{"issue":"1","key":"2573_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12882-018-1065-4","volume":"19","author":"M Matsunami","year":"2018","unstructured":"Matsunami M, Ubara Y, Sumida K, Oshima Y, Oguro M, Kinoshita K, Tanaka K, Nakamura Y, Kinowaki K, Ohashi K, Fujii T, Igawa T, Sato Y, Ishii Y. The efficacy and safety of anti-interleukin-6 receptor monoclonal blockade in a renal transplant patient with Castleman disease: early post-transplant outcome. BMC Nephrol. 2018;19(1):263.","journal-title":"BMC Nephrol"},{"issue":"24","key":"2573_CR15","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.2169\/internalmedicine.54.4183","volume":"54","author":"T Iijima","year":"2015","unstructured":"Iijima T, Hoshino J, Suwabe T, Sumida K, Mise K, Kawada M, Ueno T, Hamanoue S, Hayami N, Hiramatsu R, Sawa N, Takaichi K, Ubara Y. Tocilizumab for AA amyloidosis after treatment of multicentric castleman disease with steroids, chemotherapy and rituximab for over 20 years. Intern Med. 2015;54(24):3215\u20139.","journal-title":"Intern Med"},{"issue":"2","key":"2573_CR16","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s13730-020-00559-6","volume":"10","author":"T Tosaki","year":"2021","unstructured":"Tosaki T, Okabe M, Suzuki T, Shimizu A, Koike K, Tsuboi N, Kawamura T, Ohashi R, Yano S, Yokoo T. Membranous nephropathy with thrombotic microangiopathy-like lesions successfully treated with tocilizumab in a patient with idiopathic multicentric Castleman disease. CEN Case Rep. 2021;10(2):265\u201372.","journal-title":"CEN Case Rep"},{"issue":"7","key":"2573_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfae110","volume":"17","author":"Y Yoshimura","year":"2024","unstructured":"Yoshimura Y, Mizuno H, Ikuma D, Yamanouchi M, Sekine A, Suwabe T, Oba Y, Kurihara S, Sugimoto H, Inoue N, Yoshimoto M, Tanimizu H, Tsunoda S, Iijima M, Kono K, Kinowaki K, Ohashi K, Takazawa Y, Hasegawa E, Ubara Y, Sawa N. Long-term clinicopathological characteristics of TAFRO syndrome and its relapse: a case series study. Clin Kidney J. 2024;17(7): sfae110.","journal-title":"Clin Kidney J"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-024-02573-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-024-02573-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-024-02573-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T15:45:18Z","timestamp":1739029518000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-024-02573-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,3]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["2573"],"URL":"https:\/\/doi.org\/10.1007\/s10157-024-02573-9","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,3]]},"assertion":[{"value":"24 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no financial interests and no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present report was produced in conformity with the Declaration of Helsinki, and the patients gave their written consent for this report to be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}